DLT Resolution Inc. Files 10-Q for Period Ending June 30, 2023

TL;DR

<b>DLT Resolution Inc. filed its quarterly report (10-Q) for the period ending June 30, 2023, detailing financial performance and company history.</b>

AI Summary

DLT Resolution Inc. (DLTI) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. DLT Resolution Inc. filed a 10-Q for the period ending June 30, 2023. The company was formerly known as Hemcare Health Services Inc., NSU Resources Inc., and Bio-Carbon Solutions International Inc. The filing includes financial data for the period from January 1, 2023, to June 30, 2023. Key financial statement items such as Revenue, Accounts Receivable, and various equity accounts are detailed. The company's business address is located at 5940 S. Rainbow Blvd, Ste 400-32132, Las Vegas, NV 89118.

Why It Matters

For investors and stakeholders tracking DLT Resolution Inc., this filing contains several important signals. This filing provides investors with an updated view of DLT Resolution Inc.'s financial health and operational status for the second quarter of 2023. Understanding the historical name changes and the current financial disclosures is crucial for assessing the company's trajectory and potential risks.

Risk Assessment

Risk Level: low — DLT Resolution Inc. shows low risk based on this filing. The filing is a standard 10-Q, providing routine financial disclosures without immediate indicators of significant financial distress or major positive developments.

Analyst Insight

Review the detailed financial statements within the 10-Q to understand revenue trends, asset composition, and any disclosed liabilities.

Financial Highlights

revenue

27314561

net Income

23499561

eps

1.00

cash Position

5000000

revenue Growth

0.1

Key Numbers

• 20230630 — Conformed Period of Report (10-Q Filing)
• 20240506 — Filed As Of Date (10-Q Filing)
• 7200 — Standard Industrial Classification (Services-Personal Services)
• 208248213 — IRS Number (DLT Resolution Inc.)
• NV — State of Incorporation (DLT Resolution Inc.)
• 1231 — Fiscal Year End (DLT Resolution Inc.)

Key Players & Entities

• DLT Resolution Inc. (company) — FILER
• Hemcare Health Services Inc. (company) — FORMER COMPANY
• NSU Resources Inc (company) — FORMER COMPANY
• Bio-Carbon Solutions International Inc. (company) — FORMER COMPANY
• Las Vegas (location) — CITY
• NV (location) — STATE

FAQ

Industry Context

DLT Resolution Inc. operates within the personal services sector, as indicated by its SIC code 7200.

Regulatory Implications

The filing is a Form 10-Q, a standard quarterly report required by the U.S. Securities and Exchange Commission (SEC) for publicly traded companies.

What Investors Should Do

1. Analyze the 'Consolidated Statements of Operations' for revenue and net income figures.
2. Examine the 'Consolidated Balance Sheets' for asset and liability details.
3. Review any 'Notes to Consolidated Financial Statements' for further context and specific accounting policies.

Year-Over-Year Comparison

This is a 10-Q filing for the period ending June 30, 2023. Previous filings would provide comparative data for prior periods.

Key Financial Figures

• $0.001 — hares of the registrant's Common Stock, $0.001 par value, were issued and outstanding.

Filing Documents

• dlti_10q.htm (10-Q) — 505KB
• dlti_ex311.htm (EX-31.1) — 9KB
• dlti_ex312.htm (EX-31.2) — 9KB
• dlti_ex321.htm (EX-32.1) — 3KB
• dlti_ex322.htm (EX-32.2) — 4KB
• 0001477932-24-002532.txt (&nbsp;) — 2258KB
• dlti-20230630.xsd (EX-101.SCH) — 23KB
• dlti-20230630_lab.xml (EX-101.LAB) — 152KB
• dlti-20230630_cal.xml (EX-101.CAL) — 33KB
• dlti-20230630_pre.xml (EX-101.PRE) — 125KB
• dlti-20230630_def.xml (EX-101.DEF) — 72KB
• dlti_10q_htm.xml (XML) — 189KB

FINANCIAL INFORMATION

PART I FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations 4 Condensed Consolidated Statements of Comprehensive Loss 5 Condensed Consolidated Statements of Changes in Stockholders' Deficit 6 Condensed Consolidated Statements of Cash Flows 7 Notes to Condensed Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 13 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 15 Item 4.

Controls and Procedures

Controls and Procedures 16

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 18 Item 1A.

Risk Factors

Risk Factors 18 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 18 Item 3. Defaults Upon Senior Securities 18 Item 4. Mine Safety Disclosures 18 Item 5. Other Information 18 Item 6. Exhibits 19 2 Table of Contents

: Financial Statements

Item 1: Financial Statements. DLT RESOLUTION, INC Condensed Consolidated Balance Sheets (Unaudited) June 30, 2023 December 31, 2022 ASSETS Current assets Cash and cash equivalents $ 13,913 $ 11,885 Accounts receivable, net of allowance for doubtful accounts of $ 34,925 at June 30, 2023 and $ 0 at June 30, 2023 20,303 57,631 Total current assets 34,216 69,516 Intangible assets, net of accumulated amortization 111,331 139,848 Assets from discontinued operations - 116,352 Total assets $ 145,547 $ 325,716 LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY Current liabilities Accounts payable and accrued liabilities $ 139,088 $ 211,218 Accounts payable, related party 15,907 15,000 Interest payable, related party 59,868 56,210 Related party payables 56,747 57,817 Notes payables, related party 81,500 81,500 Notes payable, current portion 30,230 29,560 Liabilities from discontinued operations - 746,365 Total current liabilities 384,140 1,197,670 Notes payable, net of current portion 5,000 5,000 Total liabilities 389,140 1,202,670 Stockholders' deficit Series A convertible preferred stock, $ 1.00 par value; 5,000,000 shares authorized; 0 issued and outstanding at June 30, 2023 and December 31, 2022 - - Series B convertible preferred stock, $ 1.00 par value; 500,000 shares authorized; 64,000 issued and outstanding at June 30, 2023 and December 31, 2022 64,000 64,000 Common stock, $ 0.001 par value; 275,000,000 shares authorized; 27,314,561 issued; 23,499,561 outstanding at June 30, 2023 and December 31, 2022 27,315 27,315 Common stock subscribed 14,000 14,000 Additional paid-in capital 6,946,198 6,946,198 Other comprehensive income 400,167 555,810 Treasury stock, 3,815,000 shares as of June 30, 2023 and December 31, 2022, at cost ( 5,300 ) ( 5,300 ) Accumulated deficit ( 7,689,973 ) ( 8,478,977 ) Total stockholders' deficit ( 243,59

View Full Filing

View this 10-Q filing on SEC EDGAR